Daily Market News: February 17, 2026

Last updated: February 17, 2026

📰 Today’s Market Headlines

• The Stock Market Is Flashing a Clear Warning to Investors: Here’s What History Says Could Happen in 2026 and Beyond | The Motley Fool

  Feb 16, 2026 •By Adam LevyThe Trump Tariffs Are Having a Noticeable Impact on the Stock Market and It's Raising a Big Red Flag Right Now · Feb 16, 2026 •By Adria CiminoThe Stock Market Is Doing Something Witnessed Only 2 Times in 154 Years …

• Nasdaq Hits Record Highs as Tech Momentum Offsets Dow Pullback; Markets Await Nvidia Earnings – Market Updates

  The U.S. stock market delivered a split performance on Monday, February 16th, 2026, as investors navigated a landscape defined by record-breaking technology gains and a slight retreat in blue-chip stocks.

• Is US stock market and banks open, closed today, Presidents’ Day 2026?

  Most banks are closed on Presidents' … for customers. The U.S. stock market, Nasdaq and the New York Stock Exchange, will not be trading Monday….

• presidents day 2026 : US Stock Market Closed Today? Presidents Day 2026 Trading Pause Explained | US News – Times Now

  Investors logging in on Monday … in observance of Presidents' Day. Both the New York Stock Exchange and Nasdaq, along with the US bond market, are shut on Monday, February 16, for the federal holiday honouring George …

• Stock market today: Live updates

  The S&P 500 has declined two weeks in a row.

• Is the stock market open on Presidents Day? Stock market closed today?

  The New York Stock Exchange (NYSE) and Nasdaq are closed today, Monday, Feb. 16, 2026, on Presidents Day 2026, a federal holiday. The US stock market opens at 9:30 a.m. ET on Tuesday, Feb.

• Why is the stock market closed today? – AS USA

  The third Monday of February falls on the 16th in 2026, and that means no New York Stock Exchange. … Sports-lover turned journalist, born and bred in Scotland, with a passion for football (soccer).

• Prediction: These 3 Stocks Will Crush the Market in 2026 | The Motley Fool

  Rhythm currently markets only one product, Imcivree. The drug is approved for treating three rare genetic obesity disorders. However, a fourth approved indication could be right around the corner. The U.S. Food and Drug Administration (FDA) is scheduled to announce its decision on the approval of Imcivree for the treatment of acquired hypothalamic obesity (HO) by March 20, 2026. Positive news would likely cause Rhythm's shares to soar.

📊 What Analysts Are Watching

• Earnings reports from major tech companies
• Federal Reserve commentary on interest rates
• Economic data releases including jobs report
• Sector rotation between growth and value

💡 What This Means For Investors

Understanding the drivers behind daily market movements helps inform longer-term investment decisions. Focus on fundamentals while monitoring sentiment shifts. Key sectors to watch today include technology, energy, and healthcare.

Disclosure: This article is for educational purposes only and does not constitute financial advice. Always do your own research before investing.